Position in ANIK
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$497,349
+$177,012 QoQ
Shares Held
34,300
+2.9% QoQ
Ownership
0.258%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 76%
Shared 0%
None 24%
Common Shares in ANIK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026JPMORGAN CHASE & CO holds $2,053,486,048 across 61 Drug Manufacturers - Specialty & Generic names. ANIK ranks #34 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
5,442,067 | $716,937,900 | |
| 2 | ZTS |
Zoetis Inc.
|
3,387,174 | $400,397,831 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
6,762,744 | $203,693,847 | |
| 4 | ALKS |
Alkermes plc.
|
4,101,789 | $145,039,257 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
5,240,816 | $108,799,337 | |
| 6 | HLN |
Haleon plc
|
8,279,468 | $82,877,469 | |
| 7 | VTRS |
Viatris Inc
|
5,731,565 | $77,433,437 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
4,371,378 | $60,543,580 |
All Filings in ANIK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $497,349 | 34,300 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $320,337 | 33,334 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $252,511 | 26,863 | Shares | Other | 2025-11-26 | |
| 2025-06-30 | $283,659 | 26,811 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $558,287 | 37,145 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $1,357,800 | 82,491 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $383,071 | 15,509 | Shares | Other | 2024-12-26 | |
| 2024-06-30 | $673,293 | 26,581 | Shares | Other | 2024-12-26 | |
| 2024-03-31 | $695,322 | 27,375 | Shares | Other | 2024-12-26 | |
| 2023-12-31 | $687,706 | 30,349 | Shares | Other | 2024-12-26 | |
| 2023-09-30 | $267,004 | 14,332 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $469,509 | 18,072 | Shares | Other | 2023-08-11 | |
| 2023-03-31 | $428,961 | 14,936 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $333,414 | 11,264 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $252,422 | 10,606 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $217,619 | 9,750 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $214,739 | 8,552 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $350,344 | 9,778 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $282,427 | 6,636 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $288,570 | 6,666 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $258,077 | 6,327 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $405,302 | 8,955 | Shares | Defined | 2021-02-19 | |
| 2020-09-30 | $281,102 | 7,943 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $277,200 | 7,347 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $207,977 | 7,194 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||